HEALTHDAY - CANCER
2/12/2013
'Watch and Wait' Approach Often Best for Older Patients With Kidney Cancer
Posted 5:00 PM 2/12/2013 by Robert Preidt
TUESDAY, Feb. 12 (HealthDay News) -- Sometimes, simply watching and waiting is a safe alternative to surgery for older patients with small kidney tumors, a new study suggests.
"Physicians can comfortably tell an elderly patient, especially a patient that is not healthy enough to tolerate (More)
Could Duration of Prostate Cancer Hormone Therapy Be Halved?
Breast Cancer Research Needs More Focus on Environment: Report
2/11/2013
Vaccine With Drug Payload Shows Promise Against Tumors
Posted 10:00 AM 2/11/2013 by By Randy Dotinga
HealthDay Reporter
MONDAY, Feb. 11 (HealthDay News) -- Preliminary research produced promising results for a cancer-fighting drug that piggybacks on a virus similar to the one used in the smallpox vaccine.
Patients with advanced liver cancer who were given higher doses of the drug lived months longer than (More)
Benefits of Exercise on Prostate Cancer Risk May Vary by Race
2/8/2013
Pomalyst Approved for Advanced Multiple Myeloma
Posted 2:36 PM 2/8/2013 by Scott Roberts
FRIDAY, Feb. 8 (HealthDay News) -- Pomalyst (pomalidomide) has been approved by the U.S. Food and Drug Administration to treat cases of multiple myeloma that have not responded to other therapies.
The disease, a form of blood cancer, affects some 21,700 Americans annually and nearly 10,700 (More)
Avastin May Help Boost Survival With Aggressive Cervical Cancer: Study
2/7/2013
On-the-Job Stress Won't Raise Your Risk for Cancer, Study Finds
Posted 5:00 PM 2/7/2013 by By Steven Reinberg
HealthDay Reporter
THURSDAY, Feb. 7 (HealthDay News) -- The hassles and deadlines at work may leave you frazzled, but they won't raise your risk for cancer, new research suggests.
Despite earlier studies suggesting an association between work stress and cancer, an international team of researchers found that (More)
Cancer Drug Doesn't Speed Up Tumor Growth, Researchers Say
2/6/2013
FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
Posted 12:00 PM 2/6/2013 by Robert Preidt
WEDNESDAY, Feb. 6 (HealthDay News) -- Doctors need to be on the lookout for another counterfeit version of the injectable cancer drug Avastin (bevacizumab), the U.S. Food and Drug Administration warned on Wednesday.
Lab tests revealed that at least one batch of the counterfeit medicine -- (More)
2/5/2013
For Older Women, Mammograms Every 2 Years Found as Good as Annual Test
Posted 10:00 AM 2/5/2013 by By Kathleen Doheny
HealthDay Reporter
TUESDAY, Feb. 5 (HealthDay News) -- For older women ages 66 to 74, getting a mammogram every two years appears as good as getting one every year, according to a new study.
"Your risk of having breast cancer detected at a later stage is no greater if you screen every two years compared to (More)
Smoking Rates Much Higher Among the Mentally Ill: CDC
Cancer Rates Dropping Among Black Americans
Sunshine Linked to Lower Rheumatoid Arthritis Risk: Study
Benefits of CT Scans May Outweigh Cancer Risk for Young Adults
2/4/2013
First Generic Version of Cancer Drug Doxil Approved
Posted 2:00 PM 2/4/2013 by Scott Roberts
MONDAY, Feb. 4 (HealthDay News) -- The first generic version of the cancer drug Doxil (doxorubicin hydrochloride liposome injection) has been approved by the U.S. Food and Drug Administration, which says the action should help relieve shortages of the brand-name medication.
Doxil is on the (More)
With Benefits Unproven, Why Do Millions of Americans Take Multivitamins?
No Evidence That Lupus Drugs Lead to Cancer, Says Study
Hoping to Ease Shortage, FDA Fast-Tracks Generic Form of Cancer Drug
Living Near Equator May Boost Your Risk for Allergy, Asthma
As Seen On News 5
Social
Most Popular
Please select a Position and an Ad Zone.
